{"title":"Illuminating eye care: the promise and future of red light therapy in ophthalmology.","authors":"Fei Xue, Yating Zhou","doi":"10.1007/s00417-025-06800-1","DOIUrl":null,"url":null,"abstract":"<p><p>With the rapid global rise of myopia, glaucoma, AMD, and dry eye disease, red light therapy (RLT) is quickly emerging as a non-invasive, breakthrough approach with extraordinary potential to transform eye health management. Originally applied for wound healing and pain relief, RLT has shown remarkable, multi-faceted effects in ophthalmology: slowing myopia progression, protecting retinal cells in glaucoma, reducing inflammation in AMD, and relieving symptoms of dry eye disease. However, alongside the surge in research interest, questions regarding optimal dosing, safety, and standardization remain pressing. This review summarizes the latest advances of RLT in eye health, explores its mechanisms of action, analyzes safety concerns in clinical applications, and discusses its synergistic potential with existing treatment methods as well as the integration of RLT with artificial intelligence and wearable technologies. In the future, RLT is expected to play a significant role in the management of chronic ocular diseases, but its long-term effects and safety need careful evaluation, with challenges also remaining in regulatory policies and clinical standardization.</p>","PeriodicalId":12795,"journal":{"name":"Graefe’s Archive for Clinical and Experimental Ophthalmology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Graefe’s Archive for Clinical and Experimental Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00417-025-06800-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
With the rapid global rise of myopia, glaucoma, AMD, and dry eye disease, red light therapy (RLT) is quickly emerging as a non-invasive, breakthrough approach with extraordinary potential to transform eye health management. Originally applied for wound healing and pain relief, RLT has shown remarkable, multi-faceted effects in ophthalmology: slowing myopia progression, protecting retinal cells in glaucoma, reducing inflammation in AMD, and relieving symptoms of dry eye disease. However, alongside the surge in research interest, questions regarding optimal dosing, safety, and standardization remain pressing. This review summarizes the latest advances of RLT in eye health, explores its mechanisms of action, analyzes safety concerns in clinical applications, and discusses its synergistic potential with existing treatment methods as well as the integration of RLT with artificial intelligence and wearable technologies. In the future, RLT is expected to play a significant role in the management of chronic ocular diseases, but its long-term effects and safety need careful evaluation, with challenges also remaining in regulatory policies and clinical standardization.
期刊介绍：
Graefe''s Archive for Clinical and Experimental Ophthalmology is a distinguished international journal that presents original clinical reports and clini-cally relevant experimental studies. Founded in 1854 by Albrecht von Graefe to serve as a source of useful clinical information and a stimulus for discussion, the journal has published articles by leading ophthalmologists and vision research scientists for more than a century. With peer review by an international Editorial Board and prompt English-language publication, Graefe''s Archive provides rapid dissemination of clinical and clinically related experimental information.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
